Cannisco, formerly East Coast Collective, today announced its complete brand transformation, marking a new chapter for one of Virginia's most trusted vertically integrated hemp and cannabis wellness ...
The gross proceeds to MapLight from the initial public offering and the concurrent private placement, before deducting underwriting discounts and commissions and offering expenses, were $296.3 million ...
About Bioxytran, Inc. Bioxytran, Inc. is at the forefront of developing linear complex carbohydrate-based therapeutics to address critical unmet medical needs in its antiviral platform technology. For ...
About OXB OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life ...
Dewpoint Therapeutics, the leader in condensate biology, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to DPTX3186, its first-in-class ...
Basel, October 29, 2025 – Novartis today presented new ianalumab data in Sjögren’s disease, the second most prevalent rheumatic autoimmune disease 2, at a late-breaker presentation during the American ...
Plum Tree Psychology is now accepting new participants for the Hoot & Holler Chronic Illness Therapy Program. Appointments can be scheduled online at theplumtree.net/chronic-illness-therapy or by ...
The presentation is available for download on the Anaptys website here.
NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Betterguards, a sports technology innovator, today announced the launch of The BetterGuard Lite, its most accessible and lightweight innovation to date.
Real world data show >70% of patients treated with VYVGART meaningfully reduced glucocorticoid use while maintaining clinical benefit Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), ...
Telitacicept demonstrated a favorable profile comparable to placebo and consistent with prior studies across other autoimmune indications, including systemic lupus erythematosus, rheumatoid arthritis, ...
MEDIROM Healthcare Technologies Inc., (Headquarters: Minato-ku, Tokyo; President and CEO: Kouji Eguchi; listed on the Nasdaq Stock Market under the ticker symbol NASDAQ: MRM; hereinafter “the Company” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback